L2 Resource

Opioid Rehab and Treatment in Las Vegas, Nevada

Call (702) 299-6488 — Free Verification

Opioid use disorder drove more than 600 overdose deaths in Nevada in 2022, with Clark County accounting for the majority of the state's opioid mortality. The opioid epidemic in Las Vegas has shifted decisively toward illicitly manufactured fentanyl and synthetic opioids — substances that are dramatically more potent and lethal than the prescription painkillers that characterized the earlier epidemic. Inpatient opioid rehab in Las Vegas addresses this new reality with medication-assisted treatment and evidence-based behavioral care.

What Is the Most Common Treatment for Opioid Addiction?

Medication-assisted treatment (MAT) combined with behavioral therapy is the clinical gold standard for opioid use disorder. Buprenorphine (Suboxone) is the most commonly prescribed MAT medication globally — it prevents withdrawal symptoms and cravings without producing euphoria, and can be prescribed by licensed providers for long-term maintenance. Methadone is an alternative MAT option, administered through licensed opioid treatment programs (OTPs). Extended-release naltrexone (Vivitrol, a monthly injection) is effective for individuals who have completed detox and want a non-opioid approach. Inpatient programs that integrate MAT from day one — rather than waiting until discharge — produce significantly better retention and recovery outcomes.

What Is the New Treatment for Opioid Addiction?

Research continues to advance opioid use disorder treatment. Extended-release buprenorphine implants and injectable buprenorphine (Sublocade) offer monthly or six-month dosing that eliminates the daily medication requirement and reduces diversion risk. Lofexidine (Lucemyra), approved in 2018, provides non-opioid management of opioid withdrawal symptoms. Naltrexone depot injections provide 30-day blockade of opioid receptors. Digital therapeutics platforms that deliver CBT via smartphone are being integrated into inpatient and step-down programs. Psychedelic-assisted therapy for SUD is in active clinical trials but is not yet approved for clinical use.

How Much Does Opioid Treatment Cost?

Inpatient opioid treatment in Las Vegas costs $8,000 to $20,000 for a 30-day program, depending on facility type and level of services. MAT medications (buprenorphine, methadone) are typically covered as a pharmacy benefit under PPO insurance. Most PPO plans cover inpatient opioid treatment under the behavioral health benefit at the same level as other medical conditions, per MHPAEA parity requirements. A free verification call to (702) 299-6488 provides exact cost-sharing information for your specific plan.

Does Las Vegas Have a Methadone Clinic?

Yes. Las Vegas has several licensed opioid treatment programs (OTPs) that dispense methadone for opioid use disorder maintenance. These programs are regulated by the DEA and SAMHSA and require daily attendance initially, with take-home doses earned through documented compliance. Methadone maintenance is a long-term treatment option appropriate for some individuals with opioid use disorder. Inpatient programs that use buprenorphine as the primary MAT medication can transition individuals to community-based methadone programs at discharge when clinically appropriate.

Frequently Asked Questions

Opioid dependence refers to the physical adaptation of the body to opioids — producing tolerance and withdrawal when the drug is stopped. Opioid use disorder (OUD) is a broader clinical diagnosis that includes dependence along with loss of control over use, continued use despite consequences, and significant impairment in functioning. Most individuals seeking inpatient opioid rehab meet criteria for OUD, which is treated with MAT and behavioral therapy.

Inpatient opioid rehab typically lasts 30 to 90 days. Medical detox takes 5 to 14 days. NIDA recommends a minimum of 90 days of total treatment for opioid use disorder based on outcomes data. Following inpatient care, most individuals transition to MAT maintenance and outpatient support, which may continue for months to years.

Yes. Buprenorphine, methadone (when dispensed through OTPs), and naltrexone are covered by most PPO insurance plans as pharmacy or behavioral health benefits. The ACA requires coverage of MAT as an essential health benefit. Prior authorization may be required for buprenorphine. Call (702) 299-6488 to verify your specific plan's MAT coverage.

Some individuals complete opioid recovery without MAT — typically through abstinence-based programs combined with behavioral therapy. However, research consistently shows that MAT doubles or triples rates of sustained recovery at 12 months compared to abstinence-based approaches alone for opioid use disorder. The decision about whether to use MAT is a clinical one, made in collaboration with treatment providers based on the individual's history, severity of disorder, and personal preferences.

Get a Free Insurance Verification Now

Call (702) 299-6488 for a free assessment and insurance verification. PPO insurance accepted.

(702) 299-6488
Confidential · No obligation · Available 24/7
Call Now: (702) 299-6488